Continuous Infusion of Linezolid: Explaining the Discrepant Survival Outcomes between Two Studies.
作者信息
Gonze Aurélien, Gennart Thibault, De Lissnyder Nathan, Lefevre Alexis, Blackman Sydney, Honore Patrick M
机构信息
Department of Intensive Care Unit, Centre Hospitalier Universitaire UCL Namur - Site Godinne, Namur, Belgium.
Department of Surgery, Vrije Universiteit Brussel, Brussels, Belgium.
出版信息
Indian J Crit Care Med. 2025 Jul;29(7):621-622. doi: 10.5005/jp-journals-10071-24982. Epub 2025 Jul 7.
Abstract
摘要
相似文献
1
Continuous Infusion of Linezolid: Explaining the Discrepant Survival Outcomes between Two Studies.利奈唑胺持续输注：解释两项研究中不同的生存结果。
Indian J Crit Care Med. 2025 Jul;29(7):621-622. doi: 10.5005/jp-journals-10071-24982. Epub 2025 Jul 7.
2
Author Response: Continuous Infusion of Linezolid: Explaining the Discrepant Survival Outcomes between Two Studies.作者回复：利奈唑胺持续输注：解释两项研究之间相互矛盾的生存结果。
Indian J Crit Care Med. 2025 Jul;29(7):623. doi: 10.5005/jp-journals-10071-24998. Epub 2025 Jul 7.
3
Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant pneumonia.头孢洛林酯治疗耐甲氧西林肺炎患者的系统评价。
Eur Respir Rev. 2023 Oct 18;32(170). doi: 10.1183/16000617.0117-2023. Print 2023 Dec 31.
4
Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.利奈唑胺与万古霉素治疗疑似耐甲氧西林金黄色葡萄球菌医院获得性肺炎的疗效比较：一项采用荟萃分析的系统评价
Eur J Clin Pharmacol. 2015 Jan;71(1):107-15. doi: 10.1007/s00228-014-1775-x. Epub 2014 Oct 30.
5
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.欧洲视角：利奈唑胺治疗耐甲氧西林金黄色葡萄球菌医院获得性肺炎 10 余年的经验总结与更新
Clin Microbiol Infect. 2014 Apr;20 Suppl 4:19-36. doi: 10.1111/1469-0691.12450.
6
Parallel evolution of linezolid-resistant in patients with cystic fibrosis.囊性纤维化患者中耐利奈唑胺的平行进化
Microbiol Spectr. 2023 Sep 19;11(5):e0208423. doi: 10.1128/spectrum.02084-23.
7
Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.利奈唑胺限制耐甲氧西林金黄色葡萄球菌在气管导管生物膜中的负担。
Crit Care Med. 2012 Aug;40(8):2385-9. doi: 10.1097/CCM.0b013e31825332fc.
8
Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia.耐甲氧西林金黄色葡萄球菌主动监测培养作为预测耐甲氧西林金黄色葡萄球菌呼吸机相关性肺炎的工具。
Crit Care Med. 2012 May;40(5):1437-42. doi: 10.1097/CCM.0b013e318243168e.
9
A network meta-analysis of antibiotics for treatment of hospitalised patients with suspected or proven meticillin-resistant Staphylococcus aureus infection.抗生素治疗疑似或确诊耐甲氧西林金黄色葡萄球菌感染住院患者的网络荟萃分析。
Int J Antimicrob Agents. 2012 Dec;40(6):479-95. doi: 10.1016/j.ijantimicag.2012.08.004. Epub 2012 Oct 25.
10
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review.耐甲氧西林对金黄色葡萄球菌呼吸机相关性肺炎死亡率的影响：一项系统评价
Eur Respir J. 2008 Mar;31(3):625-32. doi: 10.1183/09031936.00081007.
本文引用的文献
1
Efficacy and Safety of Continuous vs Intermittent Linezolid Infusion in Critically Ill Patients with Septic Shock.连续性与间歇性利奈唑胺输注治疗感染性休克重症患者的疗效与安全性
Indian J Crit Care Med. 2024 Dec;28(12):1118-1121. doi: 10.5005/jp-journals-10071-24848. Epub 2024 Nov 30.
2
Linezolid plasma and intrapulmonary concentrations in critically ill obese patients with ventilator-associated pneumonia: intermittent vs continuous administration.危重症肥胖患者呼吸机相关性肺炎中利奈唑胺的血药浓度和肺组织浓度：间断给药与持续给药的比较。
Intensive Care Med. 2015 Jan;41(1):103-10. doi: 10.1007/s00134-014-3550-y. Epub 2014 Nov 21.
3
Subtherapeutic linezolid concentrations in a patient with morbid obesity and methicillin-resistant Staphylococcus aureus pneumonia: case report and review of the literature.病态肥胖合并耐甲氧西林金黄色葡萄球菌肺炎患者的利奈唑胺亚治疗浓度：病例报告及文献复习。
Ann Pharmacother. 2013 Jun;47(6):e25. doi: 10.1345/aph.1R707. Epub 2013 May 14.
4
Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.肥胖日本患者中利奈唑胺的药代动力学评估。
Scand J Infect Dis. 2012 Aug;44(8):626-9. doi: 10.3109/00365548.2011.652164. Epub 2012 Jan 21.
5
Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.利奈唑胺在重症脓毒症患者中的药代动力学/药效学特征：间断输注与持续输注对比
Int J Antimicrob Agents. 2008 Feb;31(2):122-9. doi: 10.1016/j.ijantimicag.2007.09.009. Epub 2007 Dec 4.
Zotero 插件